Engineering mouse T lymphocytes specific to type II collagen by transduction with a chimeric receptor consisting of a single chain Fv and TCR zeta-Reference-Cited by-同舟云学术

Engineering mouse T lymphocytes specific to type II collagen by transduction with a chimeric receptor consisting of a single chain Fv and TCR zeta

Published:2000-04 Issue:8 Volume:7 Page:714-722
ISSN:0969-7128
Container-title:Gene Therapy
language:en
Short-container-title:Gene Ther

Author:

Annenkov A,Chernajovsky Y

Publisher

Springer Science and Business Media LLC

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.nature.com/articles/3301149.pdf

Reference45 articles.

1. Feldmann M, Elliott MJ, Woody JN, Maini RN . Anti-tumor necrosis factor-alpha therapy of rheumatoid arthritis Adv Immunol 1997 64: 283–350

2. Williams RO, Feldmann M, Maini RN . Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis Proc Natl Acad Sci USA 1992 89: 9784–9788

3. Williams RO, Ghrayeb J, Feldmann M, Maini RN . Successful therapy of collagen-induced arthritis with TNF receptor-IgG fusion protein and combination with anti-CD4 Immunology 1995 84: 433–439

4. Chernajovsky Y et al. Inhibition of transfer of collagen-induced arthritis into SCID mice by ex vivo infection of spleen cells with retroviruses expressing soluble tumor necrosis factor receptor Gene Therapy 1995 2: 731–735

5. Makarov SS et al. Suppression of experimental arthritis by gene transfer of interleukin 1 receptor antagonist cDNA Proc Natl Acad Sci USA 1996 93: 402–406

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prospects for gene therapy in inflammatory arthritis;Best Practice & Research Clinical Rheumatology;2010-08

2. Cells as carriers of gene therapy;Gene Therapy for Autoimmune and Inflammatory Diseases;2010

3. Gene therapy for arthritis;Gene Therapy for Autoimmune and Inflammatory Diseases;2010

4. Gene therapy of the rheumatic diseases: 1998 to 2008;Arthritis Research & Therapy;2009

5. CD8+ T Cells Induce Complete Regression of Advanced Ovarian Cancers by an Interleukin (IL)-2/IL-15–Dependent Mechanism;Clinical Cancer Research;2007-12-01